Access the full text.
Sign up today, get DeepDyve free for 14 days.
Khursheed Iqbal, Seung-Gi Jin, G. Pfeifer, P. Szabó (2011)
Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosineProceedings of the National Academy of Sciences, 108
Peter Jones, S. Baylin (2007)
The Epigenomics of CancerCell, 128
Elisa Bergaggio, R. Piva (2019)
Wild-Type IDH Enzymes as Actionable Targets for Cancer TherapyCancers, 11
C. Allis, T. Jenuwein (2016)
The molecular hallmarks of epigenetic controlNature Reviews Genetics, 17
A. Bohring, M. Silengo, M. Lerone, D. Superneau, C. Spaich, S. Braddock, A. Poss, J. Opitz (1999)
Severe end of Opitz trigonocephaly (C) syndrome or new syndrome?American journal of medical genetics, 85 5
F. Watt, P. Molloy (1988)
Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.Genes & development, 2 9
Peter Jones, S. Baylin (2002)
The fundamental role of epigenetic events in cancerNature Reviews Genetics, 3
M. Tachibana, Y. Matsumura, Mikiko Fukuda, H. Kimura, Y. Shinkai (2008)
G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcriptionThe EMBO Journal, 27
R. Bejar, K. Stevenson, O. Abdel-Wahab, N. Galili, B. Nilsson, G. Garcia-Manero, H. Kantarjian, A. Raza, R. Levine, D. Neuberg, B. Ebert (2011)
Clinical effect of point mutations in myelodysplastic syndromes.The New England journal of medicine, 364 26
A. Feinberg, R. Ohlsson, S. Henikoff (2006)
The epigenetic progenitor origin of human cancerNature Reviews Genetics, 7
(2019)
Apparent germline IDH1 mutation in a patient with Ollier disease and glioblastomas: a case report
Hao Huang, Xi Jiang, Zejuan Li, Yuanyuan Li, Chun-Xiao Song, Chunjiang He, Miao Sun, Ping Chen, S. Gurbuxani, Jiapeng Wang, Gia-ming Hong, A. Elkahloun, Stephen Arnovitz, Jinhua Wang, Keith Szulwach, Li Lin, C. Street, M. Wunderlich, Meelad Dawlaty, Mary Neilly, R. Jaenisch, Feng-Chun Yang, J. Mulloy, P. Jin, Paul Liu, J. Rowley, Mingjiang Xu, Chuan He, Jianjun Chen (2013)
TET1 plays an essential oncogenic role in MLL-rearranged leukemiaProceedings of the National Academy of Sciences, 110
B. Panning, R. Jaenisch (1998)
RNA and the Epigenetic Regulation of X Chromosome InactivationCell, 93
A. Hoischen, B. Bon, B. Rodríguez-Santiago, C. Gilissen, L. Vissers, P. Vries, I. Janssen, Bart Lier, R. Hastings, S. Smithson, R. Newbury-Ecob, S. Kjaergaard, J. Goodship, R. McGowan, D. Bartholdi, A. Rauch, M. Peippo, J. Cobben, D. Wieczorek, G. Gillessen‐Kaesbach, J. Veltman, H. Brunner, B. Vries (2011)
De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndromeNature Genetics, 43
W. Shen, Jennifer Heeley, C. Carlston, R. Acuna-Hidalgo, W. Nillesen, K. Dent, G. Douglas, Kara Levine, P. Bayrak-Toydemir, C. Marcelis, M. Shinawi, J. Carey (2017)
The spectrum of DNMT3A variants in Tatton–Brown–Rahman syndrome overlaps with that in hematologic malignanciesAmerican Journal of Medical Genetics Part A, 173
Xiaowen Guan, Houliang Deng, Un Choi, Zhengfeng Li, Yiqi Yang, Jianming Zeng, Yunze Liu, Xuanjun Zhang, Gang Li (2020)
EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesisOncogene, 39
O. Abdel-Wahab, Mazhar Adli, Lindsay LaFave, Jie Gao, Todd Hricik, A. Shih, Suveg Pandey, Jay Patel, Y. Chung, R. Koche, F. Perna, Xinyang Zhao, Jordan Taylor, Christopher Park, M. Carroll, A. Melnick, S. Nimer, Jacob Jaffe, I. Aifantis, B. Bernstein, R. Levine (2012)
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.Cancer cell, 22 2
Mamta Tahiliani, Kian Koh, Yinghua Shen, William Pastor, Hozefa Bandukwala, Y. Brudno, Suneet Agarwal, L. Iyer, David Liu, L. Aravind, A. Rao (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 324
Lulu Hu, Ze Li, Jingdong Cheng, Q. Rao, W. Gong, Mengjie Liu, Y. Shi, Jiayu Zhu, Ping Wang, Yanhui Xu (2013)
Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC OxidationCell, 155
T. Mikeska, J. Craig (2014)
DNA Methylation Biomarkers: Cancer and BeyondGenes, 5
J. Issa, H. Kantarjian (2009)
Targeting DNA MethylationClinical Cancer Research, 15
Maria Guillamot, L. Cimmino, I. Aifantis (2016)
The Impact of DNA Methylation in Hematopoietic Malignancies.Trends in cancer, 2 2
S. Yehezkel, Y. Segev, E. Viégas-Péquignot, K. Skorecki, S. Selig (2008)
Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions.Human molecular genetics, 17 18
D. Beck, Ana Petracovici, Chongsheng He, H. Moore, R. Louie, M. Ansar, S. Douzgou, S. Sithambaram, Trudie Cottrell, R. Santos-Cortez, E. Prijoles, R. Bend, B. Keren, C. Mignot, Marie-Christine Nouguès, K. Õunap, T. Reimand, S. Pajusalu, Muhammad Zahid, M. Saqib, J. Buratti, E. Seaby, K. McWalter, A. Telegrafi, Dustin Baldridge, M. Shinawi, S. Leal, G. Schaefer, R. Stevenson, S. Banka, R. Bonasio, J. Fahrner (2020)
Delineation of a Human Mendelian Disorder of the DNA Demethylation Machinery: TET3 Deficiency.American journal of human genetics
A. Jeffries, R. Maroofian, Claire Salter, B. Chioza, H. Cross, M. Patton, I. Temple, D. Mackay, F. Rezwan, Lise Aksglæde, D. Baralle, T. Dabir, M. Hunter, Arveen Kamath, Ajith Kumar, R. Newbury-Ecob, A. Selicorni, A. Springer, L. Maldergem, V. Varghese, Naomi Yachelevich, K. Tatton-Brown, J. Mill, A. Crosby, E. Baple (2018)
Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic agingGenome Research, 29
T. Balci, Alana Strong, J. Kalish, E. Zackai, J. Maris, A. Reilly, L. Surrey, G. Wertheim, Julien Marcadier, G. Graham, M. Carter (2020)
Tatton‐Brown‐Rahman syndrome: Six individuals with novel featuresAmerican Journal of Medical Genetics Part A, 182
Shinsuke Ito, Li Shen, Qing Dai, Susan Wu, L. Collins, J. Swenberg, Chuan He, Yi Zhang (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-CarboxylcytosineScience, 333
Lulu Hu, Junyan Lu, Jingdong Cheng, Q. Rao, Ze Li, H. Hou, Z. Lou, Lei Zhang, Wei Li, W. Gong, Mengjie Liu, Chang Sun, Xiaotong Yin, Jie Li, Xiangshi Tan, Pengcheng Wang, Yinsheng Wang, Dong Fang, Q. Cui, Pengyuan Yang, Chuan He, Hualiang Jiang, C. Luo, Yanhui Xu (2015)
Structural insight into substrate preference for TET-mediated oxidationNature, 527
Jikui Song, M. Teplova, Satoko Ishibe-Murakami, D. Patel (2012)
Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA MethylationScience, 335
A. Bąk, Katarzyna Skonieczka, Anna Jaśkowiec, A. Junkiert-Czarnecka, M. Heise, Maria Pilarska-Deltow, S. Potoczek, M. Czyżewska, O. Haus (2021)
Germline mutations among Polish patients with acute myeloid leukemiaHereditary Cancer in Clinical Practice, 19
G. Genovese, A. Kähler, R. Handsaker, J. Lindberg, S. Rose, S. Bakhoum, K. Chambert, E. Mick, B. Neale, M. Fromer, S. Purcell, Oscar Svantesson, M. Landén, M. Höglund, S. Lehmann, S. Gabriel, J. Moran, E. Lander, P. Sullivan, P. Sklar, H. Grönberg, C. Hultman, S. Mccarroll (2014)
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.The New England journal of medicine, 371 26
C. Leygo, Marissa Williams, H. Jin, M. Chan, W. Chu, M. Grusch, Y. Cheng (2017)
DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of CancerDisease Markers, 2017
Iris Hollink, A. Ouweland, H. Beverloo, S. Arentsen-Peters, C. Zwaan, A. Wagner (2017)
Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar DNMT3A R882 mutationJournal of Medical Genetics, 54
R. Kosaki, H. Terashima, M. Kubota, K. Kosaki (2017)
Acute myeloid leukemia‐associated DNMT3A p.Arg882His mutation in a patient with Tatton‐Brown–Rahman overgrowth syndrome as a constitutional mutationAmerican Journal of Medical Genetics Part A, 173
Shikhar Sharma, T. Kelly, Peter Jones (2010)
Epigenetics in cancer.Carcinogenesis, 31 1
W. Hamadou, R. Abed, S. Besbes, V. Bourdon, A. Fabre, Y. Youssef, M. Laatiri, F. Eisinger, V. Mari, P. Gesta, H. Dreyfus, V. Bonadona, C. Dugast, H. Zattara, L. Faivre, S. Jemni, T. Noguchi, A. Khelif, H. Sobol, Z. Soua (2016)
Familial hematological malignancies: ASXL1 gene investigationClinical and Translational Oncology, 18
G. Egger, G. Liang, A. Aparicio, Peter Jones (2004)
Epigenetics in human disease and prospects for epigenetic therapyNature, 429
L. Cimmino, Igor Dolgalev, Yubao Wang, A. Yoshimi, G. Martin, Jingjing Wang, V. Ng, B. Xia, Matthew Witkowski, Marisa Mitchell-Flack, I. Grillo, Sofia Bakogianni, Delphine Ndiaye-Lobry, Miguel Martín, Maria Guillamot, Robert Banh, Mingjiang Xu, M. Figueroa, R. Dickins, O. Abdel-Wahab, Christopher Park, A. Tsirigos, B. Neel, I. Aifantis (2017)
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionCell, 170
M. Kranendijk, M. Kranendijk, M. Kranendijk, E. Struys, E. Struys, E. Struys, E. Schaftingen, K. Gibson, W. Kanhai, W. Kanhai, W. Kanhai, M. Knaap, J. Amiel, N. Buist, A. Das, J. Klerk, A. Feigenbaum, D. Grange, F. Hofstede, E. Holme, E. Kirk, S. Korman, E. Morava, Andrew Morris, J. Smeitink, R. Sukhai, H. Vallance, C. Jakobs, C. Jakobs, C. Jakobs, G. Salomons, G. Salomons, G. Salomons (2010)
IDH2 Mutations in Patients with d-2-Hydroxyglutaric AciduriaScience, 330
J. Pedroso, Orlando Barsottini, Ling Lin, A. Melberg, A. Oliveira, E. Mignot (2013)
A novel de novo exon 21 DNMT1 mutation causes cerebellar ataxia, deafness, and narcolepsy in a Brazilian patient.Sleep, 36 8
Alan Wright, P. Dyck (1995)
Hereditary Sensory Neuropathy With Sensorineural Deafness and Early-Onset DementiaNeurology, 45
Charly Good, Shoghag Panjarian, Andrew Kelly, J. Madzo, B. Patel, J. Jelinek, J. Issa (2018)
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.Cancer research, 78 15
KK Moghadam, F Pizza, C La Morgia, C Franceschini, C Tonon, R Lodi (2014)
Narcolepsy is a common phenotype in HSAN IE and ADCA-DNBrain, 137
(2019)
Apparent germline IDH 1 mutation in a patient with Ollier disease and glioblastomas : a case report ( P 1 . 9 – 042 )
C. Lio, Xiaojing Yue, Isaac López-Moyado, Mamta Tahiliani, L. Aravind, A. Rao (2020)
TET methylcytosine oxidases: new insights from a decade of researchJournal of Biosciences, 45
J. Micol, O. Abdel-Wahab (2016)
The Role of Additional Sex Combs-Like Proteins in Cancer.Cold Spring Harbor perspectives in medicine, 6 10
B. Lehnertz, Y. Ueda, A. Derijck, Ulrich Braunschweig, Laura Pérez-Burgos, S. Kubicek, Taiping Chen, E. Li, T. Jenuwein, A. Peters (2003)
Suv39h-Mediated Histone H3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric HeterochromatinCurrent Biology, 13
N. Duployez, Laure Goursaud, L. Fenwarth, C. Bories, A. Marceau-Renaut, T. Boyer, E. Fournier, O. Nibourel, C. Roche-Lestienne, G. Huet, D. Beauvais, C. Berthon, N. Cambier, B. Quesnel, C. Preudhomme (2019)
Familial myeloid malignancies with germline TET2 mutationLeukemia, 34
Laura Remacha, M. Currás-Freixes, R. Torres-Ruiz, F. Schiavi, R. Torres-Pérez, Bruna Calsina, R. Letón, I. Comino-Méndez, J. Roldan-Romero, C. Montero‐Conde, M. Santos, Lucía Pérez, G. Pita, M. Alonso, E. Honrado, S. Pedrinaci, B. Crespo-Facorro, A. Percesepe, M. Falcioni, S. Rodríguez-Perales, E. Korpershoek, S. Ramón-Maiques, G. Opocher, C. Rodríguez‐Antona, M. Robledo, A. Cascón (2018)
Gain-of-function mutations in DNMT3A in patients with paragangliomaGenetics in Medicine, 20
A. Kuzmichev, K. Nishioka, H. Erdjument-Bromage, P. Tempst, D. Reinberg (2002)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.Genes & development, 16 22
Eevi Kaasinen, O. Kuismin, K. Rajamäki, H. Ristolainen, M. Aavikko, Johanna Kondelin, S. Saarinen, D. Berta, Riku Katainen, Elina Hirvonen, A. Karhu, Aurora Taira, Tomas Tanskanen, A. Alkodsi, M. Taipale, E. Morgunova, K. Franssila, R. Lehtonen, M. Mäkinen, K. Aittomäki, A. Palotie, M. Kurki, O. Pietiläinen, Morgane Hilpert, Elmo Saarentaus, J. Niinimäki, J. Junttila, K. Kaikkonen, P. Vahteristo, R. Skoda, M. Seppänen, K. Eklund, J. Taipale, O. Kilpivaara, L. Aaltonen (2019)
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humansNature Communications, 10
C. Klein, M. Botuyan, Yanhong Wu, C. Ward, G. Nicholson, S. Hammans, K. Hojo, H. Yamanishi, A. Karpf, D. Wallace, M. Simon, C. Lander, L. Boardman, J. Cunningham, Glenn Smith, W. Litchy, Benjamin Boes, E. Atkinson, S. Middha, P. Dyck, J. Parisi, G. Mer, David Smith, P. Dyck (2011)
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossNature genetics, 43
J. Boultwood, Janet Perry, A. Pellagatti, M. Fernández-Mercado, C. Fernández-Santamaría, M. Calasanz, M. Larrayoz, M. García-Delgado, A. Giagounidis, L. Malcovati, M. Porta, M. Jädersten, S. Killick, E. Hellström-Lindberg, Mario Cazzola, J. Wainscoat (2010)
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemiaLeukemia, 24
Allison Norvil, D. Saha, Mohd Dar, H. Gowher (2019)
Effect of Disease-Associated Germline Mutations on Structure Function Relationship of DNA MethyltransferasesGenes, 10
R. Klose, A. Bird (2006)
Genomic DNA methylation: the mark and its mediators.Trends in biochemical sciences, 31 2
V. Shashi, L. Pena, Katherine Kim, B. Burton, M. Hempel, K. Schoch, M. Walkiewicz, H. Mclaughlin, M. Cho, N. Stong, S. Hickey, Christine Shuss, M. Freemark, J. Bellet, M. Keels, M. Bonner, M. El-Dairi, Megan Butler, P. Kranz, C. Stumpel, S. Klinkenberg, K. Oberndorff, M. Alawi, R. Santer, S. Petrovski, O. Kuismin, Satu Korpi-Heikkilä, O. Pietilainen, Palotie Aarno, M. Kurki, A. Hoischen, A. Need, D. Goldstein, F. Kortüm (2016)
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.American journal of human genetics, 99 4
M. Esteller (2005)
Aberrant DNA methylation as a cancer-inducing mechanism.Annual review of pharmacology and toxicology, 45
K. Rasmussen, K. Helin (2016)
Role of TET enzymes in DNA methylation, development, and cancerGenes & Development, 30
Robert Lorsbach, Robert Lorsbach, Jennifer Moore, Susan Mathew, S. Raimondi, S. Raimondi, S. Mukatira, James Downing, James Downing (2003)
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)Leukemia, 17
Jarmila Spegarova, Dylan Lawless, S. Mohamad, Karin Engelhardt, G. Doody, J. Shrimpton, A. Rensing-Ehl, S. Ehl, F. Rieux-Laucat, C. Cargo, H. Griffin, A. Mikulasova, M. Acres, N. Morgan, J. Poulter, E. Sheridan, P. Chetcuti, S. O'Riordan, R. Anwar, C. Carter, S. Przyborski, K. Windebank, A. Cant, M. Lako, C. Bacon, S. Savic, S. Hambleton (2020)
Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma.Blood
T. Ernst, A. Chase, J. Score, Claire Hidalgo-Curtis, C. Bryant, A. Jones, K. Waghorn, K. Zoi, F. Ross, A. Reiter, A. Hochhaus, H. Drexler, A. Duncombe, F. Cervantes, D. Oscier, J. Boultwood, F. Grand, N. Cross (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersNature Genetics, 42
A. Bohring, Grétel Oudesluijs, D. Grange, G. Zampino, P. Thierry (2006)
New cases of Bohring–Opitz syndrome, update, and critical review of the literatureAmerican Journal of Medical Genetics Part A, 140A
R. Cao, Liangjun Wang, Hengbin Wang, L. Xia, H. Erdjument-Bromage, P. Tempst, Richard Jones, Yi Zhang (2002)
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 298
J. Loscalzo, D. Handy (2014)
Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease (2013 Grover Conference Series)Pulmonary Circulation, 4
H. Cedar, Y. Bergman (2009)
Linking DNA methylation and histone modification: patterns and paradigmsNature Reviews Genetics, 10
K. Seiter, K. Htun, P. Baskind, Zach Liu (2018)
Acute myeloid leukemia in a father and son with a germline mutation of ASXL1Biomarker Research, 6
W. Hamadou, V. Bourdon, S. Letard, F. Brenet, S. Laarif, S. Besbes, A. Paci, M. David, V. Penard-Lacronique, Y. Youssef, M. Laatiri, F. Eisinger, V. Mari, P. Gesta, H. Dreyfus, V. Bonadona, C. Dugast, H. Zattara, L. Faivre, T. Noguchi, A. Khelif, C. Salem, P. Dubreuil, H. Sobol, Z. Soua (2016)
Familial hematological malignancies: new IDH2 mutationAnnals of Hematology, 95
M. Bainbridge, Hao Hu, D. Muzny, L. Musante, J. Lupski, B. Graham, B. Graham, Wei Chen, K. Gripp, Kim Jenny, T. Wienker, Yaping Yang, V. Sutton, V. Sutton, R. Gibbs, H. Ropers (2013)
De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndromeGenome Medicine, 5
DE Handy, R Castro, J Loscalzo (2011)
Epigenetic modifications: basic mechanisms and role in cardiovascular diseaseCirculation, 123
P. Blecua, L. Martinez-Verbo, M. Esteller (2020)
The DNA methylation landscape of hematological malignancies: an updateMolecular Oncology, 14
Ming Zhao, Jing Wang, W. Liao, Duo Li, Mengying Li, Haijing Wu, Yiqun Zhang, M. Gershwin, Q. Lu (2016)
Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.Journal of autoimmunity, 69
Guo-Liang Xu, T. Bestor, D. Bourc’his, C. Hsieh, N. Tommerup, M. Bugge, M. Hultén, Xiaoyan Qu, J. Russo, E. Viégas-Péquignot (1999)
Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase geneNature, 402
F. Oberklaid, D. Danks (1975)
The Opitz trigonocephaly syndrome. A case report.American journal of diseases of children, 129 11
KK Moghadam (2014)
10.1093/brain/awu069Brain, 137
Remco Molenaar, S. Sanikommu, B. Patel, B. Przychodzen, C. Noorden, T. Radivoyevitch, H. Makishima, H. Carraway, J. Maciejewski (2015)
Whole-Exome Sequencing Identifies Germline IDH2 and IDH3 mutations That Predispose to Myeloid NeoplasmsBlood, 126
C. Klein, T. Bird, N. Ertekin-Taner, S. Lincoln, R. Hjorth, Yanhong Wu, J. Kwok, G. Mer, P. Dyck, G. Nicholson (2013)
DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing lossNeurology, 80
L. Basel‐Vanagaite (2010)
Acute lymphoblastic leukemia in Weaver syndromeAmerican Journal of Medical Genetics Part A, 152A
K. Hojo, T. Imamura, M. Takanashi, Kazunari Ishii, M. Sasaki, S. Imura, Reiko Ozono, Y. Takatsuki, Shigeru Takauchi, E. Mori (1999)
Hereditary sensory neuropathy with deafness and dementia: a clinical and neuroimaging studyEuropean Journal of Neurology, 6
(2003)
containing the t ( 10 ; 11 ) ( q 22 ; q 23 )
C. Cargo, M. Cullen, Jan Taylor, M. Short, P. Glover, S. Hoppe, Alex Smith, P. Evans, S. Crouch (2019)
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis.Blood, 133 12
DE Handy (2011)
10.1161/CIRCULATIONAHA.110.956839Circulation, 123
C. Weemaes, M. Tol, Jun Wang, Jun Wang, M. Dam, M. Eggermond, P. Thijssen, C. Aytekin, N. Brunetti‐Pierri, M. Burg, E. Davies, A. Ferster, D. Furthner, G. Gimelli, A. Gennery, B. Kloeckener‐Gruissem, B. Kloeckener‐Gruissem, Stephanie Meyn, C. Powell, I. Reisli, C. Schuetz, A. Schulz, A. Shugar, P. Elsen, P. Elsen, S. Maarel (2013)
Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defectsEuropean Journal of Human Genetics, 21
Quan Zhao, Gerhard Rank, Yuen Tan, Haitao Li, Robert Moritz, Richard Simpson, L. Cerruti, David Curtis, Dinshaw J. Patel, C. Allis, John Cunningham, S. Jane (2009)
PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencingNature Structural &Molecular Biology, 16
M. Hagleitner, A. Lankester, P. Maraschio, Maj Hultén, J. Fryns, C. Schuetz, G. Gimelli, E. Davies, A. Gennery, B. Belohradsky, R. Groot, E. Gerritsen, T. Mattina, P. Howard, A. Fasth, I. Reisli, D. Furthner, M. Slatter, A. Cant, G. Cazzola, P. Dijken, M. Deuren, J. Greef, S. Maarel, C. Weemaes (2007)
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome)Journal of Medical Genetics, 45
R. Santos-Cortez, Valeed Khan, F. Khan, Z. Mughal, Imen Chakchouk, Kwanghyuk Lee, M. Rasheed, Rifat Hamza, Anushree Acharya, E. Ullah, M. Saqib, Izoduwa Abbe, G. Ali, M. Hassan, Saadullah Khan, Z. Azeem, Irfan Ullah, M. Bamshad, D. Nickerson, I. Schrauwen, W. Ahmad, M. Ansar, S. Leal (2018)
Novel candidate genes and variants underlying autosomal recessive neurodevelopmental disorders with intellectual disabilityHuman Genetics, 137
A. Cohen, Damian Yap, M. Lewis, Chieko Chijiwa, M. Ramos-Arroyo, N. Tkachenko, Valentina Milano, M. Fradin, M. McKinnon, K. Townsend, Jieqing Xu, M. Allen, C. Ross, W. Dobyns, D. Weaver, W. Gibson (2016)
Weaver Syndrome‐Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In VitroHuman Mutation, 37
P. Blackburn, J. Carter, D. Oglesbee, J. Westendorf, B. Neff, D. Stichel, D. Tsen, R. Gavrilova, P. Wesseling, A. Deimling, T. Caulfield, E. Klee, S. Pusch, C. Inwards (2020)
An activating germline IDH1 variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoidHuman Genetics and Genomics Advances, 1
Peter Jones, J. Issa, S. Baylin (2016)
Targeting the cancer epigenome for therapyNature Reviews Genetics, 17
Peter Jones, G. Veenstra, P. Wade, D. Vermaak, S. Kass, N. Landsberger, J. Strouboulis, A. Wolffe (1998)
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionNature Genetics, 19
M. Sciacovelli, Christin Schmidt, E. Maher, C. Frezza (2020)
Metabolic Drivers in Hereditary Cancer SyndromesAnnual Review of Cancer Biology
W Mayer, A Niveleau, J Walter, R Fundele, T Haaf (2000)
Demethylation of the zygotic paternal genomeNature, 403
D. Weaver, C. Graham, I. Thomas, David Smith (1974)
A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly.The Journal of pediatrics, 84 4
P. Heyn, C. Logan, Adeline Fluteau, R. Challis, Tatsiana Auchynnikava, Carol-Anne Martin, J. Marsh, Francesca Taglini, F. Kilanowski, D. Parry, V. Cormier-Daire, C. Fong, K. Gibson, V. Hwa, L. Ibáñez, S. Robertson, G. Sebastiani, J. Rappsilber, R. Allshire, Martin Reijns, A. Dauber, D. Sproul, A. Jackson (2018)
Gain of function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regionsNature genetics, 51
W. Mayer, A. Niveleau, J. Walter, R. Fundele, T. Haaf (2000)
Embryogenesis: Demethylation of the zygotic paternal genomeNature, 403
Linfeng Yang, Bin Guo, Weiwei Zhu, Lei Wang, Bingjuan Han, Yena Che, Lingfei Guo (2020)
Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case reportBMC Pediatrics, 20
Nora Rahmani, N. Ramachandra, T. Bhagat, Shanisha Gordon, K. Pradhan, Bianca Pena, Mohammad Kazemi, Orsolya Giricz, S. Maqbool, R. Olea, H. Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, A. Pellagatti, J. Boultwood, A. Verma (2019)
ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation AlterationsBlood
V. Gelsi-Boyer, V. Trouplin, J. Adélaı̈de, Julien Bonansea, N. Cervera, N. Carbuccia, A. Lagarde, T. Prebet, M. Nezri, D. Sainty, S. Olschwang, L. Xerri, M. Chaffanet, M. Mozziconacci, N. Vey, D. Birnbaum (2009)
Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 145
K. Tatton-Brown, Anne Murray, S. Hanks, J. Douglas, R. Armstrong, S. Banka, L. Bird, C. Clericuzio, V. Cormier-Daire, T. Cushing, F. Flinter, M. Jacquemont, S. Joss, E. Kinning, S. Lynch, A. Magee, V. Mcconnell, A. Medeira, K. Ozono, M. Patton, J. Rankin, D. Shears, Marleen Simon, M. Splitt, V. Strenger, K. Stuurman, Clare Taylor, Hannah Titheradge, L. Maldergem, I. Temple, T. Cole, S. Seal, N. Rahman (2013)
Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotypeAmerican Journal of Medical Genetics Part A, 161
R. Hastings, J. Cobben, G. Gillessen‐Kaesbach, J. Goodship, H. Hove, S. Kjaergaard, Helena Kemp, H. Kingston, P. Lunt, S. Mansour, R. McGowan, K. Metcalfe, C. Murdoch-Davis, M. Ray, M. Rio, S. Smithson, J. Tolmie, P. Turnpenny, B. Bon, D. Wieczorek, R. Newbury-Ecob (2011)
Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesisEuropean Journal of Human Genetics, 19
X. Nan, H. Ng, Colin Johnson, C. Laherty, B. Turner, R. Eisenman, A. Bird (1998)
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complexNature, 393
K. Tatton-Brown, S. Seal, Elise Ruark, J. Harmer, Emma Ramsay, Silvana Duarte, A. Zachariou, S. Hanks, Eleanor O’Brien, L. Aksglaede, D. Baralle, T. Dabir, B. Gener, D. Goudie, T. Homfray, Ajith Kumar, D. Pilz, A. Selicorni, I. Temple, L. Maldergem, Naomi Yachelevich, Robert Montfort, N. Rahman (2014)
Mutations in the DNA methyltransferase gene, DNMT3A, cause an overgrowth syndrome with intellectual disabilityNature genetics, 46
K. Moghadam, F. Pizza, C. Morgia, C. Franceschini, C. Tonon, R. Lodi, P. Barboni, M. Seri, S. Ferrari, R. Liguori, V. Donadio, Piero Parchi, F. Cornelio, D. Inzitari, A. Mignarri, G. Capocchi, M. Dotti, J. Winkelmann, Ling Lin, E. Mignot, V. Carelli, G. Plazzi (2014)
OP-BRAI140070 1..13
J. Winkelmann, Ling-ju Lin, B. Schormair, B. Kornum, J. Faraco, G. Plazzi, A. Melberg, F. Cornelio, A. Urban, F. Pizza, F. Poli, Fabian Grubert, T. Wieland, E. Graf, J. Hallmayer, T. Strom, E. Mignot (2012)
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.Human molecular genetics, 21 10
N. Hoang, L. Rui (2020)
DNA methyltransferases in hematological malignancies.Journal of genetics and genomics = Yi chuan xue bao
J. Tenorio, Pablo Alarcón, P. Arias, I. Dapía, S. García-Miñaúr, M. Bralo, J. Campistol, S. Climent, I. Valenzuela, Sergio Ramos, A. Monseny, Fermina Grondona, J. Botet, M. Serrano, M. Solís, F. Santos-Simarro, S. Álvarez, G. Teixidó-Tura, A. Jaén, G. Gordo, María Rivera, J. Nevado, Alicia Hernández, J. Cigudosa, V. Ruiz-Perez, E. Tizzano, Alberto Rodrígu, A. Rosa, Aleixandre Blanquer, Alfredo Alix, A. Santana, A. Delicado, A. Alonso, Amaya Rodríguez, A. Sanchis, A. Moreno, A. García, A. Vega, Analía Bredani, A. Solari, A. Villavicencio, A. Acosta, A. Nieto, Anna González, Antonio Baldellon, A. Meneses, A. Carrascal, Aranzazu Bustamante, Arteche Ocasar, B. Gener, B. González, B. Groisman, B. Coffee, C. Martín, C. Fernández, Carmen Benito, C. Armengod, C. Seisdedos, C. Roche, C. Arberas, C. Perandones, C. Pacheco, C. Contessotto, Cristina Olivas, D. Armenta, D. Cavalcanti, D. Elorza, E. Castilla, E. Zamora, E. Zambrano, E. Steichen, E. Navarro, E. Cruz, E. Gómez, E. Román, Ernesto Goldschmidt, Esteban Marfil, E. Geán, E. Antolin, F. Jimenez, F. Sarries, F. Ramos, Fermina Grondona, Fernández Córdoba, F. Santos, F. Vargas, F. Martínez, Giovannucci Uzielli, G. Gacio, G. Mercado, H. Cassinelli, I. Orioli, I. Arroyo, I. López, Ignacio Ramírez, I. Castroviejo, I. Pascual, Ignacio Rio, I. Bueno, I. Portero, I. Sánchez, J. Pozo, J. Campistol, J. Arcas, J. Fernández, J. Planells, J. Pisón, J. Barreiro, Jesús Núñez, J. Toral, Joaquín Ramírez, J. Rosell, Jorge Vilaplana, J. Almeida, J. Labarta, J. Herranz, José Luna, J. Fuster, J. Díaz, J. Gairi, J. Sagredo, J. Piñero, J. Gutiérrez, J. Fernández, J. Siguero, J. Tovar, J. Armstrong, Julián Lara, L. Soriano, Leila Cardoso, L. Arranz, Liliana Alba, L. Cimbalistienė, L. Martorell, L. Solana, Luis Jurado, M. Ariztegui, M. Molina, M. García, M. Lozano, M. Merillas, M. Martínez‐Frías, M. Jadraque, Mª Pérez, M. Pedreira, M. Guardia, M. Ribate, Manuela López, M. Pumarega, Mabel Segovia, M. Lizama, M. Lorente, M. Pombo, Miguel Martínez, M. Tabernero, M. Ramos, M. Ballesta, M. Belar, M. Lautre, Marta Cruz, M. Artigas, M. Villanueva, M. Torrabías, M. Campo, M. Vila, M. Urioste, M. Roselló, N. Rahman, Nik Kantaputra, P. Matos, P. Dorao, P. Casano, P. Mallada, P. Olivares, P. Tirado, P. Bernardi, R. León, R. Cañete, R. Gaztañaga, R. Velazquez, Ramón Samahuja, R. Delgado, R. Villaverde, R. Gracía, R. Scott, R. Valdez, R. Arteaga, R. Cedeño, R. Cazorla, R. Iglesias, R. Bronberg, S. Climent, Santiago Barreiro, S. Kapoor, S. Martín, S. Miñaur, Soledad Kleppe, S. Santillán, T. Calvo, T. Vendrell, V. González, Vanesa López, Vanesa Lotersztein, Vanesa Méndez, V. Albiach, V. Lopez, V. Soler, Viviana Cosentino, Y. Aoki, P. Lapunzina (2019)
Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patientsEuropean Journal of Human Genetics, 28
Yuxuan He, Bin-zhong Li, Zheng Li, P. Liu, Yang Wang, Qingyu Tang, Jianping Ding, Yingying Jia, Zhangcheng Chen, Lin Li, Yan Sun, Xiuxue Li, Qing Dai, Chun-Xiao Song, Kangling Zhang, Chuan He, Guo-Liang Xu (2011)
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNAScience, 333
F. Chédin, M. Lieber, C. Hsieh (2002)
The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3aProceedings of the National Academy of Sciences of the United States of America, 99
B. Russell, J. Johnston, L. Biesecker, Nancy Kramer, A. Pickart, W. Rhead, W. Tan, C. Brownstein, L. Clarkson, Amy Dobson, A. Rosenberg, S. Vergano, B. Helm, R. Harrison, J. Graham (2015)
Clinical management of patients with ASXL1 mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillanceAmerican Journal of Medical Genetics Part A, 167
Emmanuelle Viré, C. Brenner, Rachel Deplus, L. Blanchon, M. Fraga, C. Didelot, L. Morey, A. Eynde, David Bernard, J. Vanderwinden, M. Bollen, M. Esteller, L. Croce, Y. Launoit, F. Fuks (2006)
The Polycomb group protein EZH2 directly controls DNA methylationNature, 439
W. Gibson, R. Hood, S. Zhan, D. Bulman, Anthony Fejes, Richard Moore, A. Mungall, P. Eydoux, R. Babul‐Hirji, Jianghong An, M. Marra, D. Chitayat, K. Boycott, D. Weaver, Steven Jones (2012)
Mutations in EZH2 cause Weaver syndrome.American journal of human genetics, 90 1
Kartika Venugopal, Yang Feng, Daniil Shabashvili, O. Guryanova (2020)
Alterations to DNMT3A in Hematologic MalignanciesCancer Research, 81
M. Brun, Erica Lana, I. Rivals, G. Lefranc, P. Sarda, M. Claustres, A. Mégarbané, A. Sario (2011)
Heterochromatic Genes Undergo Epigenetic Changes and Escape Silencing in Immunodeficiency, Centromeric Instability, Facial Anomalies (ICF) SyndromePLoS ONE, 6
F. Delhommeau, S. Dupont, V. Valle, C. James, Severine Trannoy, A. Massé, O. Kosmider, J. Couédic, F. Robert, A. Alberdi, Y. Lécluse, I. Plo, F. Dreyfus, C. Marzac, N. Casadevall, C. Lacombe, S. Romana, P. Dessen, J. Soulier, F. Viguié, M. Fontenay, W. Vainchenker, O. Bernard (2009)
Mutation in TET2 in myeloid cancers.The New England journal of medicine, 360 22
D. Dinwiddie, S. Soden, C. Saunders, Neil Miller, E. Farrow, Laurie Smith, S. Kingsmore (2013)
De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomaliesBMC Medical Genomics, 6
F. Schaub, R. Looser, Sai Li, Hao Hui, T. Lehmann, A. Tichelli, R. Skoda (2010)
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms.Blood, 115 10
S. Baylin, Peter Jones (2016)
Epigenetic Determinants of Cancer.Cold Spring Harbor perspectives in biology, 8 9
Chun-Xiao Song, Chuan He (2013)
Potential functional roles of DNA demethylation intermediates.Trends in biochemical sciences, 38 10
O. Kosmider, V. Gelsi-Boyer, M. Ciudad, Cindy Racoeur, V. Jooste, N. Vey, B. Quesnel, P. Fenaux, J. Bastie, O. Beyne-Rauzy, A. Stamatoulas, F. Dreyfus, N. Ifrah, S. Botton, W. Vainchenker, O. Bernard, D. Birnbaum, M. Fontenay, E. Solary (2009)
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemiaHaematologica, 94
Purpose of ReviewSomatic mutations in DNA methyltransferases and other DNA methylation associated genes have been found in a wide variety of cancers. Germline mutations in these genes have been associated with several rare hereditary disorders. Among the described germline/congenital disorders, neurological dysfunction and/or growth abnormalities appear to be a common phenotype. Here, we outline known germline abnormalities and examine the cancer risks associated with these mutations.Recent FindingsThe increased use and availability of sequencing techniques in the clinical setting has expanded the identification of germline abnormalities involving DNA methylation machinery. This has provided additional cases to study these rare hereditary disorders and their predisposition to cancer.SummaryStudying these syndromes may offer an opportunity to better understand the contribution of these genes in cancer development.
Current Hematologic Malignancy Reports – Springer Journals
Published: Aug 1, 2022
Keywords: DNA methylation; Histone tail modifications; Cancer predisposition; Germline mutation; Epigenetics; Hereditary disorders
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.